“astrazeneca” Archives

in
Entry Author Date Location
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
AstraZeneca Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 05/06/20 National
ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans 04/27/20 New York
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
RDMD Lands $14M to Expand Reach of Rare Disease Research Platform 04/16/20 San Francisco
AstraZeneca Wins First FDA Drug Nod for NF1, a Rare Genetic Disorder 04/10/20 National
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs 04/09/20 Boston
Zentalis Upsizes IPO, Raising $165M for Cancer Drug Clinical Trials 04/03/20 New York
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics 03/25/20 Europe
Fears Of Recession Mount As Coronavirus Declared A Pandemic 03/19/20 National
The Benefits and Impact of Later In-Licensing Deals for Biopharma 03/17/20 National
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact 02/25/20 Boston
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More 02/21/20 National
Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs 01/31/20 San Diego
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie 01/27/20 National
After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune 01/23/20 National
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets 12/09/19 Boston
AstraZeneca, Novoheart to Co-Develop New Heart Model 11/27/19 National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund 11/06/19 National
Page 1 of 13 next page »